1. Executive Summary

2. United States Non–Invasive Prenatal Testing(NIPT) Market Analysis (2015 – 2023)
2.1 Overall Actual NIPT Test Volume & Forecast
2.1.1 Average Risk Actual NIPT Test Volume & Forecast
2.1.2 High Risk Actual NIPT Test Volume & Forecast
2.2 Overall Potential NIPT Test Volume & Forecast
2.2.1 Average Risk Potential NIPT Test Volume & Forecast
2.2.2 High Risk Potential NIPT Test Volume & Forecast
2.3 Overall Actual NIPT Test Market Revenue & Forecast
2.3.1 Average Risk Actual NIPT Test Market Revenue & Forecast
2.3.2 High Risk Actual NIPT Test Market Revenue & Forecast
2.4 Overall Potential NIPT Test Market Revenue & Forecast
2.4.1 Average Risk Potential NIPT Test Market Revenue & Forecast
2.4.2 High Risk Potential NIPT Test Market Revenue & Forecast

3. Key Drivers and Inhibitors of the United States NIPT Test Market
3.1 Market Drivers
3.2 Inhibitors

4. United States NIPT Test Market: Reimbursement & Regulation System
4.1 Reimbursement System
4.2 Regulation System

5. Non–Invasive Prenatal Testing (NIPT) Implementation – High–Income Countries
5.1.1 Clinical Issues
5.1.2 Ethical Issues
5.1.3 Legal and Regulatory Issues

6. Competitive Landscape
6.1 Non–Invasive Prenatal Testing(NIPT) – Comparative Analysis
6.2 Non–Invasive Prenatal Testing – Collaboration Deals
6.2.1 Year 2007
6.2.2 Year 2013
6.2.3 Year 2014
6.2.4 Year 2015
6.2.5 Year 2016
6.2.6 Year 2017
6.3 Non–Invasive Prenatal Testing – Venture Capital Investment
6.3.1 Year 2011
6.3.2 Year 2012
6.3.3 Year 2013
6.3.4 Year 2015
6.4 Non–Invasive Prenatal Testing – Merger and Acquisition
6.4.1 Year 2013
6.4.2 Year 2014
6.4.3 Year 2016
6.5 Non–Invasive Prenatal Testing – Exclusive Agreement
6.5.1 Year 2008
6.5.2 Year 2013
6.5.3 Year 2014
6.5.4 Year 2015
6.5.5 Year 2016
6.6 Non–Invasive Prenatal Testing – Licensing Agreement
6.6.1 Year 2007
6.6.2 Year 2011
6.6.3 Year 2013
6.6.4 Year 2014
6.6.5 Year 2015
6.7 Non–Invasive Prenatal Testing – Distribution Agreement
6.7.1 Year 2012
6.7.2 Year 2013
6.7.3 Year 2014
6.8 Non–Invasive Prenatal Testing – Partnership Deals
6.8.1 Year 2013
6.8.2 Year 2014
6.8.3 Year 2015

7. Key Companies Analysis
7.1 Sequenom Laboratories (LabCorp)
7.1.1 Business Overview
7.1.2 NIPT Test Portfolio
7.1.3 NIPT Test Analysis (Volume and Value)
7.1.3.1 Overall NIPT Test Volume & Forecast
7.1.3.2 Overall NIPT Test Market Revenue & Forecast
7.1.4 Sequenom Diagnostics – International Distributors
7.1.5 NIPT Test - Latest Development & Trends
7.2 Ariosa Diagnostics (Roche)
7.2.1 Business Overview
7.2.2 NIPT Test Portfolio
7.2.3 NIPT Test Analysis (Volume and Value)
7.2.3.1 Overall NIPT Test Volume & Forecast
7.2.3.2 Overall NIPT Test Market Revenue & Forecast
7.2.4 NIPT Test - Latest Development & Trends
7.3 Illumina
7.3.1 Business Overview
7.3.2 NIPT Test Portfolio
7.3.3 NIPT Test Analysis (Volume and Value)
7.3.3.1 Overall NIPT Test Volume & Forecast
7.3.3.2 Overall NIPT Test Market Revenue & Forecast
7.3.4 NIPT Test - Latest Development & Trends
7.4 Natera
7.4.1 Business Overview
7.4.2 NIPT Test Portfolio
7.4.3 NIPT Test Analysis (Volume and Value)
7.4.3.1 Overall NIPT Test Volume & Forecast
7.4.3.2 Overall NIPT Test Market Revenue & Forecast
7.4.4 NIPT Test - Latest Development & Trends
7.5 Quest Diagnostics
7.5.1 Business Overview
7.5.2 NIPT Test Portfolio
7.5.3 NIPT Test - Latest Development & Trends

List of Tables

Table 3 1: Maternal Age at Delivery and Risk of Down Syndrome
Table 4 1: NIPT Test CMS Price(US$),2017
Table 6 1: Non–Invasive Prenatal Testing – Comparative Tests Analysis
Table 6 2: Non–Invasive Prenatal Testing – Collaboration Deals, 2007 – 2017
Table 6 3: Non–Invasive Prenatal Testing – Venture Capital Investment, 2011 – 2015
Table 6 4: Non–Invasive Prenatal Testing – Merger & Acquisition, 2013 – 2016
Table 6 5: Non–Invasive Prenatal Testing – Exclusive Agreement, 2008 – 2016
Table 6 6: Non–Invasive Prenatal Testing – Licensing Agreement, 2007 – 2015
Table 6 7: Non–Invasive Prenatal Testing – Distribution Agreement, 2012 – 2014
Table 6 8: Non–Invasive Prenatal Testing – Partnership Deals, 2013 – 2015

List of Figures

Figure 2 1: United States – Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 2: United States – Forecast for Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 3: United States – Average Risk Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 4: United States – Forecast for Average Risk Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 5: United States – High Risk Actual NIPT Test Volume(Thousand),2015 – 2016
Figure 2 6: United States – Forecast for High Risk Actual NIPT Test Volume(Thousand),2017 – 2023
Figure 2 7: United States – Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 8: United States – Forecast for Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 9: United States – Average Risk Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 10: United States – Forecast for Average Risk Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 11: United States – High Risk Potential NIPT Test Volume(Thousand),2015 – 2016
Figure 2 12: United States – Forecast for High Risk Potential NIPT Test Volume(Thousand),2017 – 2023
Figure 2 13: United States – Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 14: United States – Forecast for Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 15: United States – Average Risk Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 16: United States – Forecast for Average Risk Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 17: United States – High Risk Actual NIPT Test Market Revenue(Million US$),2015 – 2016
Figure 2 18: United States – Forecast for High Risk Actual NIPT Test Market Revenue(Million US$),2017 – 2023
Figure 2 19: United States – Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 20: United States – Forecast for Potential NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 2 21: United States – Average Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 22: United States – Forecast for Average Risk Potential NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 2 23: United States – High Risk Potential NIPT Test Market Revenue (Million US$),2015 – 2016
Figure 2 24: United States – Forecast for High Risk Potential NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 1: Sequenom – Overall NIPT Test Volume (Thousand), 2011 – 2016
Figure 6 2: Sequenom – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 3: Sequenom - Overall NIPT Test Market Revenue (Million US$),2011 – 2016
Figure 6 4: Sequenom – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 5: Ariosa Diagnostics – Overall NIPT Test Volume (Thousand), 2012 – 2016
Figure 6 6: Ariosa Diagnostics – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 7: Ariosa Diagnostics - Overall NIPT Test Market Revenue (Million US$),2011 – 2016
Figure 6 8: Ariosa Diagnostics – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 9: Illumina – Overall NIPT Test Volume (Thousand), 2012 – 2016
Figure 6 10: Illumina – Forecast for Overall NIPT Test Volume (Thousand), 2017 – 2023
Figure 6 11: Illumina - Overall NIPT Test Market Revenue (Million US$),2012 – 2016
Figure 6 12: Illumina – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023
Figure 6 13: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2016
Figure 6 14: Natera – Overall NIPT Test Volume (Thousand), 2013 – 2016
Figure 6 15: Natera - Overall NIPT Test Market Revenue (Million US$),2013 – 2016
Figure 6 16: Natera – Forecast for Overall NIPT Test Market Revenue (Million US$),2017 – 2023